T. Rowe Price Associates
ISRG icon

T. Rowe Price Associates’s Intuitive Surgical ISRG Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.29B Sell
13,415,471
-367,772
-3% -$200M 0.83% 17
2025
Q1
$6.83B Sell
13,783,243
-686,369
-5% -$340M 0.84% 16
2024
Q4
$7.55B Sell
14,469,612
-125,824
-0.9% -$65.7M 0.87% 16
2024
Q3
$7.17B Sell
14,595,436
-1,246,054
-8% -$612M 0.83% 14
2024
Q2
$7.05B Sell
15,841,490
-688,759
-4% -$306M 0.84% 13
2024
Q1
$6.6B Sell
16,530,249
-443,017
-3% -$177M 0.81% 14
2023
Q4
$5.73B Buy
16,973,266
+272,741
+2% +$92M 0.77% 17
2023
Q3
$4.88B Sell
16,700,525
-2,321,570
-12% -$679M 0.72% 20
2023
Q2
$6.5B Sell
19,022,095
-1,402,172
-7% -$479M 0.91% 14
2023
Q1
$5.22B Sell
20,424,267
-451,175
-2% -$115M 0.78% 21
2022
Q4
$5.54B Sell
20,875,442
-3,651,588
-15% -$969M 0.89% 14
2022
Q3
$4.61B Sell
24,527,030
-1,165,705
-5% -$219M 0.75% 19
2022
Q2
$5.16B Buy
25,692,735
+816,066
+3% +$164M 0.65% 22
2022
Q1
$7.5B Buy
24,876,669
+120,648
+0.5% +$36.4M 0.76% 19
2021
Q4
$8.89B Buy
24,756,021
+16,114,776
+186% +$5.79B 0.8% 18
2021
Q3
$8.59B Sell
8,641,245
-332,801
-4% -$331M 0.81% 17
2021
Q2
$8.25B Sell
8,974,046
-20,064
-0.2% -$18.5M 0.77% 19
2021
Q1
$6.65B Sell
8,994,110
-605,982
-6% -$448M 0.67% 24
2020
Q4
$7.85B Sell
9,600,092
-554,790
-5% -$454M 0.81% 17
2020
Q3
$7.21B Sell
10,154,882
-258,300
-2% -$183M 0.83% 17
2020
Q2
$5.93B Buy
10,413,182
+150,842
+1% +$86M 0.75% 19
2020
Q1
$5.08B Sell
10,262,340
-85,109
-0.8% -$42.1M 0.8% 20
2019
Q4
$6.12B Sell
10,347,449
-47,713
-0.5% -$28.2M 0.79% 20
2019
Q3
$5.61B Buy
10,395,162
+173,139
+2% +$93.5M 0.79% 18
2019
Q2
$5.36B Sell
10,222,023
-201,937
-2% -$106M 0.75% 17
2019
Q1
$5.95B Buy
10,423,960
+33,454
+0.3% +$19.1M 0.87% 13
2018
Q4
$4.98B Buy
10,390,506
+344,349
+3% +$165M 0.84% 16
2018
Q3
$5.77B Sell
10,046,157
-377,784
-4% -$217M 0.84% 15
2018
Q2
$4.99B Buy
10,423,941
+9,173
+0.1% +$4.39M 0.76% 17
2018
Q1
$4.3B Sell
10,414,768
-1,139,039
-10% -$470M 0.68% 23
2017
Q4
$4.22B Buy
11,553,807
+7,244,996
+168% +$2.64B 0.68% 20
2017
Q3
$4.51B Sell
4,308,811
-519,459
-11% -$543M 0.77% 18
2017
Q2
$4.52B Sell
4,828,270
-413,990
-8% -$387M 0.81% 17
2017
Q1
$4.02B Buy
5,242,260
+39,182
+0.8% +$30M 0.75% 18
2016
Q4
$3.3B Buy
5,203,078
+222,686
+4% +$141M 0.66% 20
2016
Q3
$3.61B Sell
4,980,392
-452,746
-8% -$328M 0.73% 19
2016
Q2
$3.59B Sell
5,433,138
-164,059
-3% -$109M 0.76% 21
2016
Q1
$3.36B Sell
5,597,197
-766,002
-12% -$460M 0.72% 23
2015
Q4
$3.48B Buy
6,363,199
+244,659
+4% +$134M 0.73% 25
2015
Q3
$2.81B Buy
6,118,540
+62,466
+1% +$28.7M 0.63% 30
2015
Q2
$2.93B Buy
6,056,074
+291,563
+5% +$141M 0.6% 30
2015
Q1
$2.91B Buy
5,764,511
+18,811
+0.3% +$9.5M 0.6% 27
2014
Q4
$3.04B Buy
5,745,700
+105,112
+2% +$55.6M 0.65% 20
2014
Q3
$2.6B Buy
5,640,588
+1,375,156
+32% +$635M 0.57% 34
2014
Q2
$1.76B Buy
4,265,432
+2,055,592
+93% +$846M 0.38% 61
2014
Q1
$968M Buy
2,209,840
+1,537,547
+229% +$673M 0.22% 118
2013
Q4
$258M Buy
672,293
+419,710
+166% +$161M 0.06% 370
2013
Q3
$95M Buy
252,583
+42,890
+20% +$16.1M 0.02% 605
2013
Q2
$106M Buy
+209,693
New +$106M 0.03% 555